Item | Serna-Peña 2021 | Dorgham 2020 | Moghadam 2019 | Morales 2013 | Tseng 2011 |
---|---|---|---|---|---|
1.Define the source of information (survey, record review) | Yes | Yes | Yes | Yes | Yes |
2. List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications | Yes | Yes | Yes | Yes | Yes |
3. Indicate time period used for identifying patients | Yes | No | Yes | Yes | Yes |
4. Indicate whether or not subjects were consecutive if not population-based | Yes | Yes | Yes | Yes | Yes |
5. Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants | Yes | Yes | Yes | Yes | Yes |
6. Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements) | Yes | Yes | Yes | Yes | Yes |
7. Explain any patient exclusions from analysis | Yes | Yes | Yes | Yes | Yes |
8. Describe how confounding was assessed and/or controlled | Yes | Yes | Yes | Yes | Yes |
9. If applicable, explain how missing data were handled in the analysis | Unclear | Unclear | Unclear | Unclear | Unclear |
10. Summarize patient response rates and completeness of data collection | Yes | Yes | Yes | Yes | Yes |
11. Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained | Unclear | Unclear | Unclear | Unclear | Unclear |
Total score | 9 | 8 | 9 | 9 | 9 |